bioRxiv Science⌕ Search

Biology subjects

Attarwala, N.

Publications and source records attributed to Attarwala, N..

3 recordsLinked to original sources

Progesterone induces meiosis through two obligate co-receptors with PLA2 activity

The steroid hormone progesterone (P4) regulates multiple aspects of reproductive and metabolic physiology. Classical P4 signaling operates through nuclear receptors that regulate transcription. In addition, P4 signals through membrane P4 receptors (mPRs) in a rapid nongenomic modality. Despite the established physiological importance of P4 nongenomic signaling, the details of its signal transduction cascade remain elusive. Here, using Xenopus oocyte maturation as a well- established physiological readout of nongenomic P4 signaling, we identify the lipid hydrolase ABHD2 (/{beta} hydrolase domain-containing protein 2) as an essential mPR{beta} co-receptor to trigger meiosis. We show using functional assays coupled to unbiased and targeted cell-based lipidomics that ABHD2 possesses a phospholipase A2 (PLA2) activity that requires mPR{beta}. This PLA2 activity bifurcates P4 signaling by inducing clathrin-dependent endocytosis of mPR{beta}, resulting in the production of lipid messengers that are G-protein coupled receptors agonists. Therefore, P4 drives meiosis by inducing an ABHD2 PLA2 activity that requires both mPR{beta} and ABHD2 as obligate co-receptors. Significance StatementNongenomic progesterone signaling is important for many physiological functions yet the details of its signaling remain elusive. Here we define the early signaling steps downstream of membrane progesterone receptor {beta} (mPR{beta}) during Xenopus oocyte meiosis. We show that progesterone requires two cell membrane receptors to work in unison to signal. The co-receptor complex possesses lipase activity that produces lipid messenger and induces receptor endocytosis to trigger meiosis progression. Our findings have broad physiological implications because nongenomic progesterone signaling operates in many tissues and regulates reproduction and metabolism.

cell biology↗

Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma

PurposeRadiation therapy (RT) is essential for the management of glioblastoma (GBM). However, GBM frequently relapses within the irradiated margins, thus suggesting that RT might stimulate mechanisms of resistance that limits its efficacy. GBM is recognized for its metabolic plasticity, but whether RT-induced resistance relies on metabolic adaptation remains unclear. MethodsWe analyzed in vitro extracellular flux and profiled targeted metabolites as well as free fatty acids in two syngenic models of glioblastomas 24hrs post RT. Metabolic adaptation of irradiated GBM were confirmed in vivo by mass spectrometry imaging. The role of the fatty acid synthase (FASN) in RT-induced lipid metabolites was assessed by genetical and pharmacological inhibition of Fasn in irradiated GBM cells. The impact of FASN-mediated lipids on endoplasmic reticulum (ER) stress and apoptosis of irradiated GBM cells were performed by transmission electronic microscopy, western blot, clonogenic assay and flow cytometry. Inhibition of FASN combined with focal RT was assessed in mice. Analysis of a public dataset of GBM patients was performed to correlate preclinical findings. ResultsHere, we show in vitro and in vivo that irradiated GBM tumors switch their metabolic program to accumulate lipids, especially unsaturated fatty acids. This resulted in an increase formation of lipid droplets to prevent ER stress. We uncovered that FASN is critical for lipid accumulation of irradiated GBM and demonstrate that genetic suppression and pharmacological inhibition of FASN lead to mitochondrial dysfunction and apoptosis. Combination of FASN inhibition with focal RT improved the median survival of GBM-bearing mice. Supporting the translational value of these findings, retrospective analysis of the GLASS consortium dataset of matched GBM patients revealed an enrichment in lipid metabolism signature in recurrent GBM compared to primary. ConclusionsOverall, these results demonstrate that RT drives GBM resistance by generating a lipogenic environment permissive to GBM survival. Targeting lipid metabolism might be required to develop more effective anti-GBM strategies.

cell biology↗

Selective detection of m6A derived from mRNA using the Phospho-tag m6A assay

N6-methyladenosine (m6A) is a modified nucleotide found in mRNA, ribosome RNA (rRNA) and small nuclear RNA (snRNA). m6A in mRNA has important roles in regulating mRNA stability, splicing, and other processes. Numerous studies have described m6A as a dynamic modification using mass spectrometry-based quantification of m6A in mRNA samples prepared from different cellular conditions. However, these results have been questioned based on the finding that the mRNA purification protocols often result in varying levels of rRNA contamination. Additionally, mRNA purification protocols disproportionately enrich for the 3 ends of mRNA, a region that is enriched in m6A. To address these problems, we developed the Phospho-tag m6A assay, a highly efficient method for quantifying m6A specifically from mRNA. In this assay, a series of selective RNase digestion steps is performed, which results in m6A from rRNA and snRNA being liberated as m6A monophosphate, while m6A from mRNA is mostly liberated as m6A nucleoside. m6A levels are normalized to transcript levels, using m7G monophosphate liberated by yDcpS decapping enzyme as a surrogate for mRNA levels. Notably, this approach uses total cellular RNA, rather than purified mRNA, which simplifies the steps for m6A detection and overcomes the 3-end biases associated with mRNA purification. Overall, the Phospho-tag m6A provides a simple and efficient method for quantification of mRNA-derived m6A from total RNA samples.

molecular biology↗